A small longitudinal-record cohort associated higher lorazepam-equivalent sedative load with more intensive depression care. Higher load did not establish stronger treatment efficacy or medication-caused illness.
The association
The study included 106 people with first-onset major depression and at least two years of treatment records. Researchers calculated monthly medication loads, including sedative doses expressed as lorazepam equivalents.
After adjustment for other psychotropic classes and anxiety disorders, higher sedative load correlated with more antidepressants tried and more psychiatric emergency and outpatient visits during the first two years.
Equivalents have limits
The authors noted that some local benzodiazepines lacked conversion values, and available equivalents drew on withdrawal-treatment experience rather than a universally accepted potency scale. Defined daily doses for other agents also did not necessarily represent their augmentation effects.
The sample was small, several estimates were unstable, and multiple comparisons weakened confidence in isolated associations.
A useful distinction
The paper frames sedative load as a possible marker of a difficult clinical course. It does not show that sedatives caused treatment resistance or that a larger equivalent dose delivered proportionally more benefit. A forensic review should retain the original drug and dose, the conversion assumptions, and the clinical reason for changes rather than relying on one aggregate number.
Source paper
Original analysis of the supplied journal article, identified as PMC6431631.
Leave a Reply